Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Direct Meds vs MEDGm

By GLP-1 ScorecardUpdated

Direct Meds
Site position #35

Higher grade

MEDGm
Site position #312

Lower grade

Score comparison

Direct Meds has the higher recorded score — 77.6/100 to 59.1/100.

Direct Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Direct Meds prices compounded injections and sublingual bottles separately; compare the renewal charge and early cancellation cutoff before choosing a plan.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueDirect Meds +50
85
35
Dose & formulationDirect Meds +13
88
75
Clinical oversightMEDGm +5
55
60
Labs & monitoringDirect Meds +27
78
51
FulfillmentMEDGm +6
80
86
Contract termsDirect Meds +13
80
67
Direct Meds · top barMEDGm · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricDirect MedsMEDGm
WeighScore77.6/10059.1/100
GradeC+C
Site position#35#312
Semaglutide$249/30 days sublingual · $297/mo injectable$299/mo (standing rate; $179 covers the first month only)
Tirzepatide$299/30 days sublingual · $399/mo injectable$399/mo (standing rate; $279 covers the first month only)
CoverageNot publicly listedAll 50 states plus Washington, D.C.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
Direct Meds

Site position #35 · C+

FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.

Strengths

  • Injection and sublingual preparations have separately published prices
  • Pricing page advertises medication, evaluation, supplies, shipping and nurse access
  • Both semaglutide and tirzepatide are listed
  • Checked semaglutide campaign states $147 initially, then $297 monthly

What to consider

  • Compounded preparations are not FDA-approved products or assumed equivalent across routes
  • No-subscription FAQ wording conflicts with the agreement's 30-day recurring charges
  • Renewal cancellation requires 48-hour notice; initial-order cancellation has a separate conditional 24-hour window
  • Assigned prescribing practice, dispensing pharmacy and selected longer-plan total need confirmation
  • Checked campaign excludes Mississippi and Louisiana; confirm state eligibility
MEDGm

Site position #312 · C

Strengths

  • Names four dispensing pharmacies with street addresses and phone numbers
  • States its compounding class — produced in state-licensed 503A or FDA-registered facilities — rather than leaving it unsaid
  • Coverage is 50 states plus the District of Columbia and the intake's own state selector agrees with the Terms, which is rarer than it should be
  • Refills and shipping are described as included, with no separate shipping line at checkout
  • Prices an oral semaglutide lane alongside both injections

What to consider

  • The www and non-www refund policies conflict on refunds for unshipped bundle months; confirm which policy governs the chosen purchase
  • $179 and $279 are first-month injection prices; the continuing monthly prices are $299 and $399
  • Same-price-across-doses messaging does not extend the introductory discount beyond the first month
  • Annual injection plans require $2,028 or $3,228 upfront; the www refund policy excludes voluntary bundle refunds but provides medical disqualification exceptions
  • The funnel prints “prescription plan approved” and a 100% success probability before any payment and before a clinician has seen the intake, beside a twenty-minute timer that resets on reload
  • Zepbound, Wegovy and Ozempic have cards on the GLP-1 page and all six links lead to the quiz; the post-intake funnel contains none of those names
  • No principal place of business is published — only a Delaware state of formation
  • No clinician is named and no NPI appears anywhere; the site names professional entities only

Featured provider

Direct Meds

Direct Meds scores 77.6/100 (C+). Direct Meds prices compounded injections and sublingual bottles separately; compare the renewal charge and early cancellation cutoff before choosing a plan.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard